NewScen Coast Bio-Pharmaceutical's IPO

NewScen Coast Bio-Pharmaceutical raised a round of funding on December 19, 2017. Investors include Public.

NewScen Coast Bio-Pharmaceutical (天津中新科炬生物制药股份有限公司) (NEEQ: 872334), dba 科炬生物, is a medical device manufacturer committed to the research, development, productio…

Articles about NewScen Coast Bio-Pharmaceutical's IPO: